Ra Medical Systems Inc. [AMEX: RMED] plunged by -$0.33 during the normal trading session on Monday and reaching a high of $3.71 during the day while it closed the day at $3.21. The company report on May 12, 2021 that Ra Medical Systems Reports 2021 First Quarter Financial Results.
Conference call begins at 4:30 p.m. Eastern time.
Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three months ended March 31, 2021 and provides a business update.
Ra Medical Systems Inc. stock has also loss -11.08% of its value over the past 7 days. However, RMED stock has declined by -63.27% in the 3 months of the year. Over the past six months meanwhile, it has lost -34.89% and lost -56.80% year-on date.
The market cap for RMED stock reached $10.53 million, with 2.90 million shares outstanding and 2.33 million shares in the current float. Compared to the average trading volume of 1.77M shares, RMED reached a trading volume of 1431292 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Ra Medical Systems Inc. [RMED]:
Piper Jaffray have made an estimate for Ra Medical Systems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 13, 2019. While these analysts kept the previous recommendation, Maxim Group raised their target price to Buy. The new note on the price target was released on November 02, 2018, representing the official price target for Ra Medical Systems Inc. stock.
The Average True Range (ATR) for Ra Medical Systems Inc. is set at 0.62, with the Price to Sales ratio for RMED stock in the period of the last 12 months amounting to 2.39. The Price to Book ratio for the last quarter was 0.44, with the Price to Cash per share for the same quarter was set at 7.29.
RMED stock trade performance evaluation
Ra Medical Systems Inc. [RMED] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -11.08. With this latest performance, RMED shares dropped by -15.75% in over the last four-week period, additionally sinking by -34.89% over the last 6 months – not to mention a drop of -83.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RMED stock in for the last two-week period is set at 36.34, with the RSI for the last a single of trading hit 35.76, and the three-weeks RSI is set at 36.73 for Ra Medical Systems Inc. [RMED]. The present Moving Average for the last 50 days of trading for this stock 4.63, while it was recorded at 3.51 for the last single week of trading, and 6.34 for the last 200 days.
Ra Medical Systems Inc. [RMED]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Ra Medical Systems Inc. [RMED] shares currently have an operating margin of -812.58 and a Gross Margin at -24.45. Ra Medical Systems Inc.’s Net Margin is presently recorded at -818.27.
Return on Total Capital for RMED is now -114.22, given the latest momentum, and Return on Invested Capital for the company is -118.13. Return on Equity for this stock declined to -132.77, with Return on Assets sitting at -93.00. When it comes to the capital structure of this company, Ra Medical Systems Inc. [RMED] has a Total Debt to Total Equity ratio set at 23.10. Additionally, RMED Total Debt to Total Capital is recorded at 18.77, with Total Debt to Total Assets ending up at 14.61. Long-Term Debt to Equity for the company is recorded at 18.17, with the Long-Term Debt to Total Capital now at 14.76.
Reflecting on the efficiency of the workforce at the company, Ra Medical Systems Inc. [RMED] managed to generate an average of -$424,059 per employee. Receivables Turnover for the company is 8.60 with a Total Asset Turnover recorded at a value of 0.11.Ra Medical Systems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.30 and a Current Ratio set at 3.60.
Earnings per share (EPS) analysis for Ra Medical Systems Inc. [RMED] stock
With the latest financial reports released by the company, Ra Medical Systems Inc. posted -14/share EPS, while the average EPS was predicted by analysts to be reported at -8.62/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -62.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RMED.
Ra Medical Systems Inc. [RMED]: Insider Ownership positions
There are presently around $3 million, or 24.90% of RMED stock, in the hands of institutional investors. The top three institutional holders of RMED stocks are: ROYCE & ASSOCIATES LP with ownership of 317,583, which is approximately 56.207% of the company’s market cap and around 7.90% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 155,502 shares of the stock with an approximate value of $0.5 million in RMED stocks shares; and DOWLING & YAHNKE LLC, currently with $0.22 million in RMED stock with ownership of nearly New of the company’s market capitalization.
Positions in Ra Medical Systems Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 14 institutional holders increased their position in Ra Medical Systems Inc. [AMEX:RMED] by around 397,754 shares. Additionally, 6 investors decreased positions by around 16,752 shares, while 3 investors held positions by with 370,073 shares. The mentioned changes placed institutional holdings at 784,579 shares, according to the latest SEC report filing. RMED stock had 11 new institutional investments in for a total of 268,659 shares, while 4 institutional investors sold positions of 16,332 shares during the same period.